Myriad Genetics sell JPMorgan Chase & Co.
Start price
07.11.23
/
50%
€16.70
Target price
07.11.24
€13.08
Performance (%)
2.40%
End price
08.11.24
€17.10
Summary
This prediction ended on 08.11.24 with a price of €17.10. With a performance of 2.40%, the SELL prediction by JPMorgan_Chase___Co_ for Myriad Genetics was trending in the wrong direction JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Myriad Genetics | -8.097% | -8.097% | -61.849% |
| iShares Core DAX® | -1.432% | 0.000% | 12.331% |
| iShares Nasdaq 100 | -0.386% | -0.595% | 4.688% |
| iShares Nikkei 225® | 1.448% | 5.269% | 18.051% |
| iShares S&P 500 | 0.114% | -0.217% | 1.388% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Myriad Genetics diskutieren
Myriad Genetics, Inc. (NASDAQ: MYGN) had its price target lowered by analysts at JPMorgan Chase & Co. from $17.00 to $14.00. They now have an "underweight" rating on the stock.
Ratings data for MYGN provided by MarketBeat
In the thread Trading Myriad Genetics
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten